Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
atenolol beta-1 adrenergic receptor small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Disease Management[MeSHID:D019468]
Hypertensive disease[MeSHID:D006973]
Cardiac Arrhythmia[MeSHID:D001145]
Systolic Pressure[MeSHID:D001794]
Angina Pectoris[MeSHID:D000787]
Heart failure[MeSHID:D006333]
Thyrotoxicosis[MeSHID:D013971]
Supraventricular tachycardia[MeSHID:D013617]
heart rate[MeSHID:D006339]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Myocardial Infarction[MeSHID:D009203]
Arrhythmogenic Right Ventricular Dysplasia[MeSHID:D019571]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.61 approved antagonist
atenolol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Disease Management[MeSHID:D019468]
Hypertensive disease[MeSHID:D006973]
Cardiac Arrhythmia[MeSHID:D001145]
Systolic Pressure[MeSHID:D001794]
Angina Pectoris[MeSHID:D000787]
Heart failure[MeSHID:D006333]
Thyrotoxicosis[MeSHID:D013971]
Supraventricular tachycardia[MeSHID:D013617]
heart rate[MeSHID:D006339]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Myocardial Infarction[MeSHID:D009203]
Arrhythmogenic Right Ventricular Dysplasia[MeSHID:D019571]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.61 approved antagonist
atenolol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Disease Management[MeSHID:D019468]
Hypertensive disease[MeSHID:D006973]
Cardiac Arrhythmia[MeSHID:D001145]
Systolic Pressure[MeSHID:D001794]
Angina Pectoris[MeSHID:D000787]
Heart failure[MeSHID:D006333]
Thyrotoxicosis[MeSHID:D013971]
Supraventricular tachycardia[MeSHID:D013617]
heart rate[MeSHID:D006339]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Myocardial Infarction[MeSHID:D009203]
Arrhythmogenic Right Ventricular Dysplasia[MeSHID:D019571]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.61 approved unknown
atenolol beta-2 adrenergic receptor small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Disease Management[MeSHID:D019468]
Hypertensive disease[MeSHID:D006973]
Cardiac Arrhythmia[MeSHID:D001145]
Systolic Pressure[MeSHID:D001794]
Angina Pectoris[MeSHID:D000787]
Heart failure[MeSHID:D006333]
Thyrotoxicosis[MeSHID:D013971]
Supraventricular tachycardia[MeSHID:D013617]
heart rate[MeSHID:D006339]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Myocardial Infarction[MeSHID:D009203]
Arrhythmogenic Right Ventricular Dysplasia[MeSHID:D019571]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved antagonist
click here to return to the previous page